💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A weak business.
Wockhardt is scored on the pharma / healthcare framework. It keeps a slim 5.7% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 1.96× reported profit. Free cash flow is worth about 0.5% of its market value.
Book value has grown 13%/yr. Return on equity is a weak 8.0%. In the latest quarter profit fell 35% versus the prior quarter.
It trades at 78× earnings. Today's price already implies ~28%/yr earnings growth sustained for a decade — a demanding bar. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 78.09 | — | — |
| P/B | 6.13 | 4.1 | worse |
| EV/EBITDA | 38.17 | 19.33 | worse |
| ROE | 7.95 | — | — |
| ROCE | 8.89 | 14.41 | worse |
| ROA | 4.55 | 1.64 | better |
| Quick Ratio | 1.06 | 4.8 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Sun Pharmaceutical Industries | 40.6 | 5.0 | 13.8% |
| Divis Laboratories | 93.5 | 16.3 | 15.3% |
| Torrent Pharmaceuticals | 85.9 | 9.8 | 11.4% |
Revenue has grown every year across all 4 financial years shown. 8% CAGR — growing but slowly. Growth is accelerating — latest year outpaced the prior year's rate.
3 of the 4 years shown had a loss — profitability is inconsistent. The latest year saw a +449% swing — check if it's a one-off or structural.
Operating margin has expanded from -23% to 7% — the business is keeping more of each rupee earned.
ROE at 4% — modest; the capital isn't working hard. Capital efficiency improving — ROE up 21pp across the window.
EPS has grown every year — each share earns more than the last, consistently.
1 of 4 years had negative operating cash flow — profitability on paper may not translate to cash. Cash conversion at 2.0× PAT — earnings are well-backed by cash; strong accrual quality. Heavy investing spend every year, but operations generate enough to cover it — the business self-funds its growth.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue broadly flat QoQ — stable but not accelerating. Run-rate stepping up — recent quarters average 15% above earlier ones.
Profit fell 35% QoQ — one-quarter drops can be noise, but a pattern matters.
P/E band unavailable — needs 5y of consistent EPS + price history.
Promoters at 49.3% — dispersed ownership; institutional flows drive the stock.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.